Stepan Reports Higher Second Quarter Earnings, Up 22%

NORTHFIELD, Ill., July 27, 2011 /PRNewswire/ -- Stepan Company (NYSE: SCL) today reported higher second quarter and year-to-date results for the period ended June 30, 2011.

  • Net income rose 22 percent to $20.9 million compared to $17.0 million a year ago.  Earnings per share also rose 22 percent to $1.87 per share.
  • Net income, excluding deferred compensation plan expense, was $20.7 million compared to $19.2 million a year ago, up eight percent.
  • Net sales rose 30 percent primarily due to higher selling prices.  Gross profit rose 10 percent despite commodity raw material inflation.  Total sales volume grew by less than one percent as six percent higher polymer volumes were offset by a one percent decrease in surfactant volumes.

SUMMARY



Three Months Ended June 30


Six Months Ended June 30

($ in thousands, except per share amounts)


2011


2010

% Change



2011


2010

% Change









Net Sales

$476,989

$366,504

+ 30


$899,587

$703,534

+ 28









Net Income

20,867

17,046

+ 22


39,628

37,706

+ 5









Net Income Excluding

  Deferred Compensation*


20,680


19,163


+ 8



38,904


38,490


+ 1









Earnings per Diluted Share

$1.87

$1.53

+ 22


$3.55

$3.41

+ 4









Earnings per Diluted Share

  Excluding Deferred

  Compensation



$1.85



$1.72



+ 8




$3.49



$3.48











*  See Table II for a discussion of deferred compensation plan accounting.




SECOND QUARTER RESULTS






Three Months Ended June 30


Six Months Ended June 30

($ in thousands)


2011


2010

% Change



2011


2010

% Change









Net Sales








  Surfactants

$343,767

$264,567

+ 30


$668,652

$526,880

+ 27

  Polymers

120,854

90,893

+ 33


207,253

154,003

+ 35

  Specialty Products

12,368

11,044

+ 12


23,682

22,651

+ 5

      Total Net Sales

$476,989

$366,504

+ 30


$899,587

$703,534

+ 28




Net sales rose by 30 percent due to higher selling prices (25 percent) and the effect of foreign currency translation (five percent).  Sales volume grew by less than one percent.  A six percent increase in polymer sales volume was largely offset by a one percent decline in surfactant volume.

  • Surfactant sales volume declined by one percent due to weaker volumes in Consumer Products partially offset by improved sales in the Agricultural and Oil Field segments.   Oil Field volume improvement was driven by increased sales into EOR applications.
  • Polymer sales volume rose six percent.  Sales volume of polyol, used primarily in rigid foam insulation rose by 12 percent.  External sales of phthalic anhydride (PA) declined by 10 percent, while profitability improved on higher margins.  The lower PA volume relates to recurring weakness in polyester resins used in automotive, boating and construction industries.  Internal consumption of PA increased on higher polyol volumes.

Gross profit increased by 10 percent to $69.6 million versus $63.5 million a year ago.

  • Surfactant gross profit rose by $1.5 million, or three percent, due to a more favorable sales mix in North America and Europe that was partially offset by lower Consumer Product sales.  Latin American gross profit declined due to higher expenses associated with our Brazilian expansion.  Latin American volume grew by 22 percent.
  • Polymer gross profit surged 37 percent to $20.6 million compared to $15.0 million a year ago.  The improvement was largely due to the 12 percent increase in polyol volume coupled with improved margins, particularly in Europe, which had experienced margin erosion over the last year as commodity raw material costs escalated.  We anticipate continued strong demand for polyol used in replacement roofs driven by energy savings and expanded use in metal panel applications.
  • Specialty Products gross profit declined four percent to $4.4 million versus $4.6 million a year ago.  The decrease is due to lower margins in our food ingredient business precipitated by higher raw material costs and competitive pressure on selling prices.  Sales volume rose eight percent.

OPERATING EXPENSES



Three Months Ended June 30


Six Months Ended June 30

($ in thousands)


2011


2010

% Change



2011


2010

% Change









Marketing

  $12,171

   $9,391

  + 30


  $23,001

  $20,342

  + 13

Administrative – General

   13,008

   11,543

  + 13


   24,263

   22,407

   + 8

Administrative – Deferred

 Compensation


    (328)


    2,730


   NM



    (709)


      929


   NM

Research, development

 and technical service


    10,656


    10,042


   + 6



     20,887


     19,925


   + 5

   Total

  $35,507

  $33,706

   + 5


  $67,442

  $63,603

   + 6




  • Marketing expense rose 30 percent for the quarter and 13 percent year-to-date.  Investments planned to accelerate growth in Singapore, Brazil and Poland and the consolidation of the Philippine operation accounted for nearly half of the growth in marketing expense.  Higher travel expense and the effect of foreign currency translation of expenses incurred outside the U.S. contributed to the remaining increase.
  • Administrative general expense rose by 13 percent for the quarter and eight percent for the year.  The growth initiatives in Singapore, Brazil and Poland contributed to the increase coupled with the effect of foreign currency translation.

INCOME TAXES

The effective tax rate was 33 percent for the quarter and 32 percent for the year-to-date period compared to 35 percent in the year ago periods.  The decrease was primarily attributable to the implementation of a holding company structure that will provide a recurring benefit in lowering the effective tax rate on foreign earnings.

BALANCE SHEET

The Company's net debt levels increased by $32.2 million for the quarter and increased $84.8 million for the first six months:


($in millions)








Net Debt

6/30/11

3/31/11

12/31/10

  Total Debt

$190.8

$185.7

$191.6

  Cash

25.6

52.7

111.2

  Net Debt

$165.2

$133.0

$80.4




The year-to-date increase in net debt was primarily due to the inflationary impact of higher commodity raw material costs on inventory and receivables. The second quarter increase also included the Lipid Nutrition product line acquisition, including inventory. Capital expenditures for the quarter and year-to-date periods were $17.9 million and $40.4 million, respectively.

OUTLOOK

Our growth initiatives are on track to deliver future earnings in 2012.  Surfactant earnings will improve this year as growth from our higher margin functional surfactants offset the weakness in consumer volumes.  Surfactant demand for enhanced oil recovery continues to grow.  Our Brazil expansion is complete and we will have improved contribution in the third quarter.  

The significant improvement in our Polymer business this year is in line with our expectations.  The sold out demand for polyol at our German plant will continue to require imports from our Illinois plant for the balance of the year due to delays in the expanded German capacity.  Our polymer plant in Poland should see improved volume over the balance of the year as we begin fulfilling new customer demand.

Specialty Product earnings will benefit from our recently announced Lipid Nutrition product line acquisition.  The acquisition should contribute to earnings this year and provide longer term synergies with our existing food ingredient business.

While 2011 will have some planned higher costs associated with our global growth initiatives, we have the opportunity to deliver full year earnings growth.

CONFERENCE CALL

Stepan Company will host a conference call to discuss the second quarter results at 1:00 p.m. Eastern Daylight Time on July 27, 2011. To listen to a live webcast of this call, please go to our Internet website at: www.stepan.com, click on investor relations, next click on conference calls and follow the directions on the screen.

Stepan Company, headquartered in Northfield, Illinois, is a leading producer of specialty and intermediate chemicals used in household, industrial, personal care, agricultural, food and insulation related products.  The common and the convertible preferred stocks are traded on the New York and Chicago Stock Exchanges under the symbols SCL and SCLPR.

* * * * *

tables follow

Except for historical information, all other information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied.  The most significant of these uncertainties are described in Stepan Company's Form 10-K, Form 8-K and Form 10-Q reports and exhibits to those reports, and include (but are not limited to), prospects for our foreign operations, foreign currency fluctuations, certain global and regional economic conditions, the probability of future acquisitions and the uncertainties related to the integration of acquired businesses, the probability of new products, the loss of one or more key customer or supplier relationships, the costs and other effects of governmental regulation and legal and administrative proceedings, including the expenditures necessary to address and resolve environmental claims and proceedings, and general economic conditions.  These forward-looking statements are made only as of the date hereof, and Stepan Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

Table I


STEPAN COMPANY

Statements of Income

For the Three and Six Months Ended June 30, 2011 and 2010

(Unaudited – 000's Omitted)


















Three Months Ended

June 30


Six Months Ended

June 30



2011


2010

% Change



2011


2010

% Change









Net Sales

$476,989

$366,504

 +   30


$899,587

$703,534

 +   28

Cost of Sales

 407,404

303,026

 +   34


768,216

576,504

 +   33

  Gross Profit

69,585

63,478

 +   10


131,371

127,030

 +    3









Operating Expenses:








  Marketing

12,171

9,391

 +   30


23,001

20,342

 +   13

  Administrative

12,680

14,273

 -   11


23,554

23,336

 +    1

  Research, development

      and technical services


 10,656


 10,042


 +    6



20,887


19,925


 +    5


35,507

33,706

 +    5


67,442

63,603

 +    6









Operating Income

34,078

29,772

 +   14


63,929

63,427

 +    1

Other Income (Expense):








  Interest, net

(2,194)

(1,510)

 +   45


(4,257)

(2,766)

 +   54

  Loss from equity in joint ventures

   (805)

   (764)

 +    5


   (1,770)

   (1,335)

 +   33

  Other, net

    253

    (1,111)

    NM


   565

   (1,333)

    NM


(2,746)

(3,385)

 -   19


(5,462)

(5,434)

 +    1









Income before Income Taxes

31,332

26,387

 +   19


58,467

57,993

 +    1

Provision for Income Taxes

10,326

 9,318

 +   11


 18,645

 20,243

 -     8

Net Income

21,006

17,069

 +   23


39,822

37,750

 +    5









Add: Net Income Attributable to
the Noncontrolling Interests


     (139)


      (23)


 +  504



       (194)


       (44)


 +  341









Net Income Attributable to

  Stepan Company


$20,867


$17,046


 +   22



$39,628


$37,706


 +    5

Net Income Per Common Share

Attributable to Stepan Company








  Basic

$2.00

$1.66

 +   20


$3.80

$3.69

 +    3

  Diluted

$1.87

$1.53

 +   22


$3.55

$3.41

 +    4









Shares Used to Compute Net

Income Per Common Share Attributable
to Stepan Company








  Basic

10,345

10,160

 +    2


10,335

10,130

 +    2

  Diluted

11,178

11,118

 +    1


11,175

11,052

 +    1




Table II

Deferred Compensation Plan

The full effect of the deferred compensation plan on quarterly pretax income was $0.3 million of income versus expense of $3.4 million last year.  The accounting for the deferred compensation plan results in income when the price of Stepan Company common stock or mutual funds held in the plan fall and expense when they rise.  The Company also recognizes the change in value of mutual funds as investment income or loss.  The deferred compensation expense income statement impact is summarized below:



Three Months Ended June 30


Six Months Ended June 30

($in thousands)

2011

2010


2011

2010







Deferred Compensation






  Administrative (Expense) Income

$328

$(2,730)


$709

$(929)

  Other, net – Mutual Fund Gain (Loss)

(26)

(685)


460

(336)

      Total Pretax

$302

$(3,415)


$1,169

$(1,265)







      Total After Tax

$187

$(2,117)


$724

$(784)




Reconciliation of non-GAAP net income:



Three Months Ended June 30


Six Months Ended June 30

($ in thousands)

2011

2010


2011

2010







Net income excluding deferred

  compensation


$20,680


$19,163



$38,904


$38,490

Deferred compensation plan (expense)

  income


       187


    (2,117)



      724


      (784)

Net income as reported

$20,867

$17,046


$39,628

$37,706




Reconciliation of non-GAAP EPS:



Three Months Ended June 30


Six Months Ended June 30


2011

2010


2011

2010







Earnings per diluted share excluding

  deferred compensation


$1.85


$1.72



$3.49


$3.48

Deferred compensation plan (expense)

  income


 0.02


(0.19)



   0.06


(0.07)

Earnings per diluted share

$1.87

$1.53


$3.55

$3.41




The Company believes that certain non-GAAP measures, when presented in conjunction with comparable GAAP (Generally Accepted Accounting Principles) measures, are useful because that information is an appropriate measure for evaluating the Company's operating performance.  Internally, the Company uses this non-GAAP information as an indicator of business performance, and evaluates management's effectiveness with specific reference to these indicators.  These measures should be considered in addition to, neither a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP.

Table III

Effects of Foreign Currency Translation

The Company's foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because foreign exchange rates fluctuate against the U.S. dollar over time, foreign currency translation affects period-to-period comparisons of financial statement items (i.e. because foreign exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results). For the second quarter and the first half of 2011, the U.S. dollar was weaker against all the foreign currencies in the locations where the Company does business, when compared to the exchange rates for the second quarter and first half of 2010. Consequently, reported net sales, expense and income amounts for 2011 were higher than they would have been had the foreign currency exchange rates remained constant with the rates for 2010. Below is a table that presents the effect that foreign currency translation had on the quarter-over-quarter and year-over-year changes in consolidated net sales and various income line items for the second quarter and first half ending June 30, 2011:



Three Months Ended June 30




2011

2010

Increase

Increase Due to

Foreign Translation






Net Sales

$477.0

$366.5

110.5

16.6

Gross Profit

69.6

63.5

6.1

1.5

Operating Income

34.1

29.8

4.3

0.6

Pretax Income

31.3

26.4

4.9

0.4






Six Months

Ended June 30




2011

2010

Increase

Increase Due to

Foreign Translation






Net Sales

$899.6

$703.5

196.1

20.1

Gross Profit

131.4

127.0

4.4

1.9

Operating Income

63.9

63.4

0.5

0.9

Pretax Income

58.5

58.0

0.5

0.6




Table IV

Stepan Company

Consolidated Balance Sheets

June 30, 2011 and December 31, 2010





2011

June 30

2010

December 31

ASSETS






Current Assets

$504,592

$427,826




Property, Plant & Equipment, Net

368,766

353,585




Other Assets

37,567

30,020




  Total Assets

$910,925

$811,431







LIABILITIES AND STOCKHOLDERS' EQUITY






Current Liabilities

$262,534

$205,627




Deferred Income Taxes

9,986

5,154




Long-term Debt

154,956

159,963




Other Non-current Liabilities

82,462

87,616




Total Stepan Company Stockholders' Equity

397,171

349,491




Minority Interest

3,816

3,580




  Total Liabilities and Stockholders' Equity

$910,925

$811,431




SOURCE Stepan Company



RELATED LINKS
http://www.stepan.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.